Spiriva

What is it?

Composition

The composition of the drug Spiriva includes the active substance tiotropium bromide. This is the key component that determines the effectiveness of the drug in the treatment of respiratory diseases. In addition to the active substance, Spiriva contains excipients that improve its effectiveness.

• Tiotropium bromide is the main active component that provides relaxation of the respiratory tract muscles.
• Excipients that ensure the stability and ease of use of the drug.

These components work in harmony to provide the patient with easier breathing and reduce the frequency and severity of attacks, improving the quality of life.

How to use?

Spiriva should be used strictly according to the doctors instructions. Correct use of the medicine can significantly improve the effectiveness of the treatment. For most patients, the recommended dose is two inhalations by mouth once a day. Always follow the instructions on the package.

1. Open the package and prepare the HandiHaler for use.
2. Load one capsule into the device in the specified way to release the medicine into the inhaler chamber.
3. Take two inhalations in a row to get the full dose from one capsule.
4. Do not take the capsule by mouth, it is only for use in the HandiHaler.

Following these simple steps is essential for the medicine to work properly and reduce the symptoms of respiratory failure.

How does it work?

Spiriva works by blocking certain chemicals in the body that cause the airways to narrow. Tiotropium, the main ingredient, helps relax the smooth muscles of the airways, causing them to widen and facilitate airflow into the lungs. Through this mechanism of action, the drug effectively reduces shortness of breath and improves overall lung function.

Long-term use of Spiriva helps maintain a stable condition in patients with chronic lung diseases. This is especially important for people with COPD, as it can significantly reduce the frequency of exacerbations and improve quality of life. Spiriva is unique in that it provides a long-lasting effect, which allows it to be used only once a day and achieve a significant increase in the patients respiratory function.

Indications

Spiriva is indicated for use as a long-term maintenance treatment in patients with chronic obstructive pulmonary disease and asthma. This includes the prevention of chronic dyspnea and improvement of overall ventilation.

• Prevention of bronchospasm in adults with COPD, including bronchitis and emphysema.
• Prevention of asthma attacks in adults and children over 6 years of age.

Because of its effectiveness in controlling symptoms, Spiriva allows patients to lead a more active lifestyle and reduces the risk of hospitalization due to exacerbations of the disease.

Contraindications

Despite its effectiveness, Spiriva has a number of contraindications that should be taken into account before starting treatment. The drug should not be used by certain categories of patients due to the risk of adverse reactions.

• Allergy to tiotropium or ipratropium.
• Use in children under 6 years of age.
• The drug is intended for inhalation use with HandiHaler only and should not be taken orally.

Before starting treatment, it is necessary to discuss all possible contraindications with your doctor to ensure the safety of therapy and reduce risks.

Side effects

Like any medicine, Spiriva can cause side effects that can range from mild to more serious. Patients should be aware of possible reactions and consult a doctor if necessary.

• Allergic reactions, including hives and difficulty breathing.
• Vision problems, such as blurred vision or pain in the eyes.
• Dry mouth, upset stomach, chest pain and rapid heartbeat.
• Cold symptoms, including nasal congestion or sore throat.

If any of these symptoms occur, it is recommended to seek medical attention promptly to prevent worsening of the condition.